Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Consolidated Net Income (2018 - 2025)

Historic Consolidated Net Income for Neurogene (NGNE) over the last 5 years, with Q3 2025 value amounting to -$21.1 million.

  • Neurogene's Consolidated Net Income fell 365.48% to -$21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.8 million, marking a year-over-year decrease of 2393.35%. This contributed to the annual value of -$75.7 million for FY2024, which is 4376.38% down from last year.
  • According to the latest figures from Q3 2025, Neurogene's Consolidated Net Income is -$21.1 million, which was down 365.48% from -$23.2 million recorded in Q2 2025.
  • Neurogene's 5-year Consolidated Net Income high stood at -$11.9 million for Q2 2023, and its period low was -$23.2 million during Q2 2025.
  • Its 3-year average for Consolidated Net Income is -$17.8 million, with a median of -$18.6 million in 2024.
  • As far as peak fluctuations go, Neurogene's Consolidated Net Income tumbled by 5713.92% in 2024, and later crashed by 365.48% in 2025.
  • Quarter analysis of 3 years shows Neurogene's Consolidated Net Income stood at -$14.0 million in 2023, then plummeted by 40.71% to -$19.7 million in 2024, then dropped by 7.35% to -$21.1 million in 2025.
  • Its Consolidated Net Income stands at -$21.1 million for Q3 2025, versus -$23.2 million for Q2 2025 and -$22.8 million for Q1 2025.